Basic and Diluted Net Loss per Share

9 Months Ended

Oct. 31, 2023

The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the three and nine months ended October 31, 2023 and 2022:


	Three Months Ended October 31,				Nine Months Ended October 31,
	2023		2022		2023		2022
	(in thousands, except share and per share data)
Numerator:
Net loss	$	(158,219)	$	(84,480)	$	(362,861)	$	(266,446)








Denominator:
Weighted average common shares outstanding	376,190,781		339,674,302		360,836,403		337,135,962
Less: Weighted average unvested restricted shares and shares subject to repurchase	(7,998)		(78,917)		(18,272)		(98,851)
Weighted average shares outstanding - Basic and Diluted	376,182,783		339,595,385		360,818,131		337,037,111




Net loss per share - Basic and Diluted	$	(0.43)	$	(0.25)	$	(1.01)	$	(0.79)

The potential shares of Common Stock that were excluded from the computation of diluted net loss per share attributable to common stockholders at each period end because including them would have had an antidilutive effect were as follows:


	October 31, 2023	October 31, 2022
2028 Convertible Notes (on an as-converted basis)	24,999,990	12,483,569
Options to purchase common stock	13,042,440	18,785,716
Restricted stock units	21,609,427	13,030,259
Unvested early exercised common stock options	4,692	67,318
Common stock warrants	34,499,436	34,587,257
Employee stock purchase plan	8,751,276	1,660,491
Total potentially dilutive common share equivalents	102,907,261	80,614,610

PRSUs granted were excluded from the above table because the respective stock price targets have not been met as of October 31, 2023.